VIAF

Virtual International Authority File

Search

Leader     00000nz a2200037n 45 0
001     WKP|Q42608425  (VIAF cluster)  (Authority/Source Record)
003     WKP
005     20241121000204.0
008     241121nneanz||abbn n and d
035 ‎‡a  (WKP)Q42608425‏
024 ‎‡a  0000-0001-5192-8878‏ ‎‡2  orcid‏
024 ‎‡a  22954229200‏ ‎‡2  scopus‏
024 ‎‡a  56637450500‏ ‎‡2  scopus‏
035 ‎‡a  (OCoLC)Q42608425‏
100 0 ‎‡a  Heng Luo‏ ‎‡9  ast‏ ‎‡9  es‏ ‎‡9  sl‏
400 0 ‎‡a  Heng Luo‏ ‎‡c  researcher (ORCID 0000-0001-5192-8878)‏ ‎‡9  en‏
400 0 ‎‡a  Heng Luo‏ ‎‡c  onderzoeker‏ ‎‡9  nl‏
670 ‎‡a  Author's A rat RNA-Seq transcriptomic BodyMap across 11 organs and 4 developmental stages‏
670 ‎‡a  Author's Applying network analysis and Nebula (neighbor-edges based and unbiased leverage algorithm) to ToxCast data‏
670 ‎‡a  Author's Combining Docking Pose Rank and Structure with Deep Learning Improves Protein-Ligand Binding Mode Prediction over a Baseline Docking Approach‏
670 ‎‡a  Author's Comparing genetic variants detected in the 1000 genomes project with SNPs determined by the International HapMap Consortium‏
670 ‎‡a  Author's Comparison of RNA-seq and microarray-based models for clinical endpoint prediction‏
670 ‎‡a  Author's Competitive molecular docking approach for predicting estrogen receptor subtype α agonists and antagonists‏
670 ‎‡a  Author's DDI-CPI, a server that predicts drug-drug interactions through implementing the chemical-protein interactome‏
670 ‎‡a  Author's Development and Validation of Decision Forest Model for Estrogen Receptor Binding Prediction of Chemicals Using Large Data Sets‏
670 ‎‡a  Author's DPDR-CPI, a server that predicts Drug Positioning and Drug Repositioning via Chemical-Protein Interactome‏
670 ‎‡a  Author's Drug repositioning for diabetes based on 'omics' data mining‏
670 ‎‡a  Author's Estrogenic activity data extraction and in silico prediction show the endocrine disruption potential of bisphenol A replacement compounds‏
670 ‎‡a  Author's Exploring off-targets and off-systems for adverse drug reactions via chemical-protein interactome--clozapine-induced agranulocytosis as a case study‏
670 ‎‡a  Author's Haystack, a web-based tool for metabolomics research‏
670 ‎‡a  Author's HLADR: a database system for enhancing the discovery of biomarkers for predicting human leukocyte antigen-mediated idiosyncratic adverse drug reactions.‏
670 ‎‡a  Author's Machine Learning Methods for Predicting HLA-Peptide Binding Activity‏
670 ‎‡a  Author's Machine-Learning Prediction of Oral Drug-Induced Liver Injury (DILI) via Multiple Features and Endpoints‏
670 ‎‡a  Author's Molecular Docking for Identification of Potential Targets for Drug Repurposing.‏
670 ‎‡a  Author's Molecular Docking for Prediction and Interpretation of Adverse Drug Reactions‏
670 ‎‡a  Author's Molecular docking to identify associations between drugs and class I human leukocyte antigens for predicting idiosyncratic drug reactions.‏
670 ‎‡a  Author's SePreSA: a server for the prediction of populations susceptible to serious adverse drug reactions implementing the methodology of a chemical-protein interactome‏
670 ‎‡a  Author's sNebula, a network-based algorithm to predict binding between human leukocyte antigens and peptides‏
670 ‎‡a  Author's Understanding and predicting binding between human leukocyte antigens (HLAs) and peptides by network analysis‏
670 ‎‡a  Author's Whole genome sequencing of 35 individuals provides insights into the genetic architecture of Korean population‏
909 ‎‡a  (scopus) 56637450500‏ ‎‡9  1‏
909 ‎‡a  (scopus) 22954229200‏ ‎‡9  1‏
909 ‎‡a  (orcid) 0000000151928878‏ ‎‡9  1‏
919 ‎‡a  estrogenicactivitydataextractionandinsilicopredictionshowtheendocrinedisruptionpotentialofbisphenolareplacementcompounds‏ ‎‡A  Estrogenic activity data extraction and in silico prediction show the endocrine disruption potential of bisphenol A replacement compounds‏ ‎‡9  1‏
919 ‎‡a  drugrepositioningfordiabetesbasedonomicsdatamining‏ ‎‡A  Drug repositioning for diabetes based on 'omics' data mining‏ ‎‡9  1‏
919 ‎‡a  dpdrcpiaserverthatpredictsdrugpositioninganddrugrepositioningviachemicalproteininteractome‏ ‎‡A  DPDR-CPI, a server that predicts Drug Positioning and Drug Repositioning via Chemical-Protein Interactome‏ ‎‡9  1‏
919 ‎‡a  developmentandvalidationofdecisionforestmodelforestrogenreceptorbindingpredictionofchemicalsusinglargedatasets‏ ‎‡A  Development and Validation of Decision Forest Model for Estrogen Receptor Binding Prediction of Chemicals Using Large Data Sets‏ ‎‡9  1‏
919 ‎‡a  ddicpiaserverthatpredictsdrugdruginteractionsthroughimplementingthechemicalproteininteractome‏ ‎‡A  DDI-CPI, a server that predicts drug-drug interactions through implementing the chemical-protein interactome‏ ‎‡9  1‏
919 ‎‡a  competitivemoleculardockingapproachforpredictingestrogenreceptorsubtypeαagonistsandantagonists‏ ‎‡A  Competitive molecular docking approach for predicting estrogen receptor subtype α agonists and antagonists‏ ‎‡9  1‏
919 ‎‡a  comparisonofrnaseqandmicroarraybasedmodelsforclinicalendpointprediction‏ ‎‡A  Comparison of RNA-seq and microarray-based models for clinical endpoint prediction‏ ‎‡9  1‏
919 ‎‡a  comparinggeneticvariantsdetectedinthe1000genomesprojectwithsnpsdeterminedbytheinternationalhapmapconsortium‏ ‎‡A  Comparing genetic variants detected in the 1000 genomes project with SNPs determined by the International HapMap Consortium‏ ‎‡9  1‏
919 ‎‡a  combiningdockingposerankandstructurewithdeeplearningimprovesproteinligandbindingmodepredictionoverabaselinedockingapproach‏ ‎‡A  Combining Docking Pose Rank and Structure with Deep Learning Improves Protein-Ligand Binding Mode Prediction over a Baseline Docking Approach‏ ‎‡9  1‏
919 ‎‡a  applyingnetworkanalysisandnebulaneighboredgesbasedandunbiasedleveragealgorithmtotoxcastdata‏ ‎‡A  Applying network analysis and Nebula (neighbor-edges based and unbiased leverage algorithm) to ToxCast data‏ ‎‡9  1‏
919 ‎‡a  ratrnaseqtranscriptomicbodymapacross11organsand4developmentalstages‏ ‎‡A  A rat RNA-Seq transcriptomic BodyMap across 11 organs and 4 developmental stages‏ ‎‡9  1‏
919 ‎‡a  wholegenomesequencingof35individualsprovidesinsightsintothegeneticarchitectureofkoreanpopulation‏ ‎‡A  Whole genome sequencing of 35 individuals provides insights into the genetic architecture of Korean population‏ ‎‡9  1‏
919 ‎‡a  understandingandpredictingbindingbetweenhumanleukocyteantigenshlasandpeptidesbynetworkanalysis‏ ‎‡A  Understanding and predicting binding between human leukocyte antigens (HLAs) and peptides by network analysis‏ ‎‡9  1‏
919 ‎‡a  snebulaanetworkbasedalgorithmtopredictbindingbetweenhumanleukocyteantigensandpeptides‏ ‎‡A  sNebula, a network-based algorithm to predict binding between human leukocyte antigens and peptides‏ ‎‡9  1‏
919 ‎‡a  sepresaaserverforthepredictionofpopulationssusceptibletoseriousadversedrugreactionsimplementingthemethodologyofachemicalproteininteractome‏ ‎‡A  SePreSA: a server for the prediction of populations susceptible to serious adverse drug reactions implementing the methodology of a chemical-protein interactome‏ ‎‡9  1‏
919 ‎‡a  moleculardockingtoidentifyassociationsbetweendrugsandclass1humanleukocyteantigensforpredictingidiosyncraticdrugreactions‏ ‎‡A  Molecular docking to identify associations between drugs and class I human leukocyte antigens for predicting idiosyncratic drug reactions.‏ ‎‡9  1‏
919 ‎‡a  moleculardockingforpredictionandinterpretationofadversedrugreactions‏ ‎‡A  Molecular Docking for Prediction and Interpretation of Adverse Drug Reactions‏ ‎‡9  1‏
919 ‎‡a  moleculardockingforidentificationofpotentialtargetsfordrugrepurposing‏ ‎‡A  Molecular Docking for Identification of Potential Targets for Drug Repurposing.‏ ‎‡9  1‏
919 ‎‡a  machinelearningpredictionoforaldruginducedliverinjurydiliviamultiplefeaturesandendpoints‏ ‎‡A  Machine-Learning Prediction of Oral Drug-Induced Liver Injury (DILI) via Multiple Features and Endpoints‏ ‎‡9  1‏
919 ‎‡a  machinelearningmethodsforpredictinghlapeptidebindingactivity‏ ‎‡A  Machine Learning Methods for Predicting HLA-Peptide Binding Activity‏ ‎‡9  1‏
919 ‎‡a  hladradatabasesystemforenhancingthediscoveryofbiomarkersforpredictinghumanleukocyteantigenmediatedidiosyncraticadversedrugreactions‏ ‎‡A  HLADR: a database system for enhancing the discovery of biomarkers for predicting human leukocyte antigen-mediated idiosyncratic adverse drug reactions.‏ ‎‡9  1‏
919 ‎‡a  haystackawebbasedtoolformetabolomicsresearch‏ ‎‡A  Haystack, a web-based tool for metabolomics research‏ ‎‡9  1‏
919 ‎‡a  exploringofftargetsandoffsystemsforadversedrugreactionsviachemicalproteininteractomeclozapineinducedagranulocytosisasacasestudy‏ ‎‡A  Exploring off-targets and off-systems for adverse drug reactions via chemical-protein interactome--clozapine-induced agranulocytosis as a case study‏ ‎‡9  1‏
996 ‎‡2  LC|n 85009596‏
996 ‎‡2  LC|n 2016005819‏
996 ‎‡2  LC|n 2019183648‏
996 ‎‡2  LC|n 2024054601‏
996 ‎‡2  ISNI|0000000390665825‏
996 ‎‡2  ISNI|000000047475485X‏
996 ‎‡2  LC|no2002007915‏
996 ‎‡2  SUDOC|234167459‏
996 ‎‡2  SUDOC|188153675‏
996 ‎‡2  CYT|AC000634688‏
996 ‎‡2  LC|n 85157316‏
996 ‎‡2  DNB|1306326249‏
996 ‎‡2  DNB|136278027‏
996 ‎‡2  DNB|1314805533‏
996 ‎‡2  J9U|987008729440505171‏
996 ‎‡2  CAOONL|ncf10219653‏
996 ‎‡2  ISNI|0000000025419773‏
996 ‎‡2  NTA|379205920‏
996 ‎‡2  DNB|1059928922‏
996 ‎‡2  LC|no2023009674‏
996 ‎‡2  NLR|RU NLR AUTH 770185797‏
996 ‎‡2  ISNI|0000000496889974‏
996 ‎‡2  DNB|1216277311‏
996 ‎‡2  ISNI|0000000433890708‏
996 ‎‡2  DNB|140742654‏
996 ‎‡2  LC|no2023108608‏
996 ‎‡2  NTA|364178744‏
996 ‎‡2  ISNI|0000000119017353‏
996 ‎‡2  SUDOC|233328963‏
996 ‎‡2  J9U|987007329049805171‏
996 ‎‡2  LC|n 2014025988‏
996 ‎‡2  CYT|AC000248855‏
996 ‎‡2  J9U|987007418480805171‏
996 ‎‡2  LC|no2020008002‏
996 ‎‡2  PLWABN|9812423054605606‏
996 ‎‡2  NTA|421076348‏
996 ‎‡2  NTA|331437767‏
996 ‎‡2  J9U|987007400139005171‏
996 ‎‡2  LC|no2017168258‏
996 ‎‡2  DNB|1163542768‏
996 ‎‡2  NTA|416682391‏
996 ‎‡2  DNB|1300089520‏
996 ‎‡2  ISNI|0000000063691057‏
996 ‎‡2  DNB|1309117675‏
996 ‎‡2  CYT|AC000631942‏
996 ‎‡2  BNF|16566506‏
996 ‎‡2  DNB|121991407X‏
996 ‎‡2  ISNI|000000007738498X‏
996 ‎‡2  LC|nb2018005663‏
996 ‎‡2  ISNI|0000000498921181‏
996 ‎‡2  ISNI|0000000074867994‏
996 ‎‡2  CYT|AC000649029‏
996 ‎‡2  ISNI|0000000501161276‏
996 ‎‡2  DNB|1284495957‏
996 ‎‡2  BNF|16949426‏
996 ‎‡2  DNB|1069694053‏
996 ‎‡2  ISNI|0000000063692746‏
996 ‎‡2  LC|no2011062650‏
996 ‎‡2  CYT|AC000635150‏
996 ‎‡2  DNB|119035669‏
996 ‎‡2  NSK|000663521‏
997 ‎‡a  0 0 lived 0 0‏ ‎‡9  1‏
998 ‎‡a  Heng, Luo‏ ‎‡2  PLWABN|9812728699605606‏ ‎‡3  exact name‏